NorthRock Partners’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.61M | Sell |
14,947
-1,533
| -9% | -$165K | 0.04% | 164 |
|
|
2025
Q1 | $1.66M | Buy |
16,480
+217
| +1% | +$21.9K | 0.06% | 138 |
|
|
2024
Q4 | $1.45M | Sell |
16,263
-660
| -4% | -$59K | 0.05% | 151 |
|
|
2024
Q3 | $1.42M | Buy |
16,923
+2,030
| +14% | +$170K | 0.05% | 168 |
|
|
2024
Q2 | $1.15M | Buy |
14,893
+702
| +5% | +$54.1K | 0.04% | 180 |
|
|
2024
Q1 | $972K | Buy |
14,191
+517
| +4% | +$35.4K | 0.04% | 206 |
|
|
2023
Q4 | $790K | Buy |
13,674
+6,152
| +82% | +$356K | 0.03% | 225 |
|
|
2023
Q3 | $397K | Buy |
7,522
+1,391
| +23% | +$73.4K | 0.04% | 190 |
|
|
2023
Q2 | $332K | Sell |
6,131
-717
| -10% | -$38.8K | 0.04% | 199 |
|
|
2023
Q1 | $343K | Sell |
6,848
-240
| -3% | -$12K | 0.04% | 201 |
|
|
2022
Q4 | $328K | Buy |
+7,088
| New | +$328K | 0.04% | 231 |
|
|
2022
Q2 | – | Sell |
-6,614
| Closed | -$293K | – | 312 |
|
|
2022
Q1 | $293K | Buy |
6,614
+1,819
| +38% | +$80.6K | 0.03% | 247 |
|
|
2021
Q4 | $204K | Buy |
+4,795
| New | +$204K | 0.02% | 315 |
|
|
2016
Q4 | – | Sell |
-13,587
| Closed | -$323K | – | 58 |
|
|
2016
Q3 | $323K | Sell |
13,587
-1,543
| -10% | -$36.7K | 0.14% | 28 |
|
|
2016
Q2 | $354K | Buy |
15,130
+12,119
| +402% | +$284K | 0.16% | 27 |
|
|
2016
Q1 | $56K | Buy |
+3,011
| New | +$56K | 0.03% | 47 |
|
|
2015
Q3 | – | Sell |
-22,403
| Closed | -$397K | – | 46 |
|
|
2015
Q2 | $397K | Sell |
22,403
-3,465
| -13% | -$61.4K | 0.18% | 29 |
|
|
2015
Q1 | $459K | Buy |
25,868
+1,750
| +7% | +$31.1K | 0.27% | 24 |
|
|
2014
Q4 | $320K | Buy |
+24,118
| New | +$320K | 0.2% | 28 |
|